The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
For eight years, the nonprofit Salt Lake Harm Reduction Project has served Salt Lake and its surrounding communities. A main goal is to provide syringe exchanges to reduce the harm caused by drug use, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback